Brian M. Goldberg

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Experience10 yrs

Elite Ratings

DCT,

PTAB,

CAFC

Practice Areas

Communications (150 cases)

Biotech (140 cases)

Design (130 cases)

Law Firms

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Experience

Grade

Trend

DCT

PTAB

CAFC

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Case #	Court	Caption	Filed	Represent
1:00-CV-00001	E.D. TX	Par Pharmaceutical, Inc. v. Alkem Laboratories Ltd.	09/01/23	Patent Owner : Samsung Electronics Co Ltd
1:00-CV-00002	E.D. TX	Par Pharmaceutical Inc v. Mankind Pharma Ltd	09/01/23	Challenger (L) : Apple Inc
1:00-CV-00003	D. DE	Par Pharmaceutical Inc v. Zydus Pharma USA Inc	08/08/23	Patent Owner : Google LLC
1:00-CV-00004	D. DE	Genzyme Corp v. Novartis Gene Therapies Inc	05/19/23	Challenger (W) : Microsoft Corp
1:00-CV-00005	D. DE	Arius Two Inc v. Xiromed LLC	09/12/22	Patent Owner (L) : LG Electronics Inc
1:00-CV-00006	D. NJ	Par Pharmaceutical Inc v. Cipla Ltd	05/13/22	Challenger : Facebook Inc
1:00-CV-00007	D. DE	Genzyme Corp v. Novartis Gene Therapies Inc	12/10/21	Patent Owner (W) : Intel Corp
1:00-CV-00008	D. NJ	Par Pharmaceutical Inc v. Eagle Pharma Inc	12/07/20	Challenger (W) : Uniloc USA Inc
1:00-CV-00009	D. NJ	Par Pharmaceutical Inc v. Aurobindo Pharma USA Inc	12/07/20	Patent Owner : Sony Corp
1:00-CV-00010	D. NJ	Par Pharmaceutical Inc v. Amneal Eu Ltd	12/07/20	Challenger (L) : Cisco Systems Inc